Movement disorders: Phase I trials

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects

E2027

Phase I

Parkinsons, dementia

United States

Recruiting

https://clinicaltrials.gov/ct2/show/NCT02873156?term=parkinsons&rcv_s=07%2F25%2F2016&rcv_e=08%2F25%2F2016&lup_s=07%2F25%2F2016&lup_e=08%2F25%2F2016&rank=11


Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA (AFF009)

AFFITOPE® PD01A + Adjuvant

Phase I

France

Recruiting

Click here for further information


Ampicillin for DYT-1 Dystonia Motor Symptoms

Ampicillin

Phase I

United States

Recruiting

Click here for further information